Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 1c, Revenue Beats; Guides Higher

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $101.3 million versus the consensus estimate of $91.17 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2022 revenue of $103-106 million, versus the consensus of $92.45 million.

Hims & Hers Health, Inc. sees FY2022 revenue of $410-425 million, versus the consensus of $377.85 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Pfizer reaffirms 2026 guidance after CFO transition news
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS